Evidence map›Paper›PMID 28853436›Full record

ArticleNature communications2017

Small nucleoli are a cellular hallmark of longevity.

Varnesh Tiku, Chirag Jain, Yotam Raz, Shuhei Nakamura, Bree Heestand, Wei Liu, Martin Späth, H Eka D Suchiman, Roman-Ulrich Müller, P Eline Slagboom and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 186 papers.

0numbers the graph read from it
0cells of the map it votes in
186citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

186 citing papers in PubMed, 286 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Deciphering the impact ofGenes & diseases · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Resolving Sub-Nuclear Architecture from Compartments to Functional Domains.International journal of molecular sciences · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

126 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Varnesh TikuMax Planck Institute for Biology of Ageing, Joseph Stelzmann Strasse 9b, 50931 Cologne, Germany.
Chirag JainMax Planck Institute for Biology of Ageing, Joseph Stelzmann Strasse 9b, 50931 Cologne, Germany.
Yotam RazSection of Molecular Epidemiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.ORCID 0000-0001-9628-632X
Shuhei NakamuraDepartment of Genetics, Graduate School of Medicine, Osaka University 2-2 Yamadaoka, Suita 565-0871, Japan.ORCID 0000-0002-1488-8317
Bree HeestandLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-3280, USA.
Wei LiuDepartment of Molecular and Cellular Biology, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas 77030, USA.
Martin SpäthCologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50674 Cologne, Germany.
H Eka D SuchimanSection of Molecular Epidemiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Roman-Ulrich MüllerCologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50674 Cologne, Germany.
P Eline SlagboomSection of Molecular Epidemiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Linda PartridgeMax Planck Institute for Biology of Ageing, Joseph Stelzmann Strasse 9b, 50931 Cologne, Germany.
Adam AntebiMax Planck Institute for Biology of Ageing, Joseph Stelzmann Strasse 9b, 50931 Cologne, Germany.
University of Cologne · DELeiden University Medical Center · NLBaylor College of Medicine · USMax Planck Institute for Biology of Ageing · DEMuseum of Japanese Art Yamato Bunkakan · JPUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal lifespan is regulated by conserved metabolic signalling pathways and specific transcription factors, but whether these pathways affect common downstream mechanisms remains largely elusive. Here we show that NCL-1/TRIM2/Brat tumour suppressor extends lifespan and limits nucleolar size in the major C. elegans longevity pathways, as part of a convergent mechanism focused on the nucleolus. Long-lived animals representing distinct longevity pathways exhibit small nucleoli, and decreased expression of rRNA, ribosomal proteins, and the nucleolar protein fibrillarin, dependent on NCL-1. Knockdown of fibrillarin also reduces nucleolar size and extends lifespan. Among wildtype C. elegans, individual nucleolar size varies, but is highly predictive for longevity. Long-lived dietary restricted fruit flies and insulin-like-peptide mutants exhibit small nucleoli and fibrillarin expression, as do long-lived dietary restricted and IRS1 knockout mice. Furthermore, human muscle biopsies from individuals who underwent modest dietary restriction coupled with exercise also display small nucleoli. We suggest that small nucleoli are a cellular hallmark of longevity and metabolic health conserved across taxa.

Indexed as

Cell NucleolusAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCaloric RestrictionCarrier ProteinsChromosomal Proteins, Non-HistoneDrosophilaExerciseGene Knockdown TechniquesHumansInsulin Receptor Substrate ProteinsLongevityMetabolic Networks and PathwaysMice, KnockoutMuscle, SkeletalCaenorhabditis elegans ProteinsCarrier ProteinsChromosomal Proteins, Non-Histonefib-1 protein, C elegansfibrillarinInsulin Receptor Substrate ProteinsIrs1 protein, mousencl-1 protein, C elegansRibosomal ProteinsRNA-Binding ProteinsRNA, Ribosomal

Identifiers

PMID28853436
PMCPMC5582349
OpenAlexW2752671881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.